Citi Pharma Ltd. has announced the acquisition of a 20% shareholding in Pakheim International Pharma (Private) Limited as part of a larger strategy to acquire 100% of the company. This acquisition marks a significant step in Citi Pharma's expansion efforts within the pharmaceutical sector.
- Acquisition of 20% stake in Pakheim International Pharma (Private) Limited.
- This is the first tranche of a proposed total acquisition of 100%.
- The acquisition is in accordance with a Share Purchase Agreement dated May 6, 2026.
- Further developments will be communicated to the Pakistan Stock Exchange as required.